Welcome to LookChem.com Sign In|Join Free

CAS

  • or

4548-34-9

Post Buying Request

4548-34-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4548-34-9 Usage

Description

TranylcyproMine (2-PCPA) HCl is a monoamine oxidase inhibitor that selectively inhibits the enzyme CYP2A6, with Ki values of 0.08 μM in cDNA-expressing microsomes and 0.2 μM in Human Liver Microsomes. This property makes it a valuable compound in various applications across different industries.

Uses

Used in Pharmaceutical Industry:
TranylcyproMine (2-PCPA) HCl is used as a monoamine oxidase inhibitor for its ability to selectively inhibit the enzyme CYP2A6. This makes it a potential candidate for the development of treatments targeting various neurological and psychiatric disorders, as well as other conditions where monoamine oxidase inhibition can be beneficial.
Used in Research Applications:
In the field of research, TranylcyproMine (2-PCPA) HCl is used as a tool compound to study the role of monoamine oxidase enzymes in various biological processes. Its selective inhibition of CYP2A6 allows researchers to investigate the specific functions and interactions of this enzyme in cellular and molecular studies.
Used in Drug Development:
TranylcyproMine (2-PCPA) HCl is utilized in drug development as a lead compound for the creation of new medications targeting monoamine oxidase enzymes. Its high specificity for CYP2A6 makes it a promising starting point for designing drugs with improved efficacy and reduced side effects compared to existing treatments.
Used in Toxicology Studies:
In toxicology, TranylcyproMine (2-PCPA) HCl is employed as a reference compound to evaluate the potential toxic effects of other substances on the monoamine oxidase enzyme system. Its well-defined inhibitory profile helps researchers understand the mechanisms of action and potential risks associated with exposure to various chemicals and compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 4548-34-9 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,5,4 and 8 respectively; the second part has 2 digits, 3 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 4548-34:
(6*4)+(5*5)+(4*4)+(3*8)+(2*3)+(1*4)=99
99 % 10 = 9
So 4548-34-9 is a valid CAS Registry Number.

4548-34-9Relevant articles and documents

Diastereoselective Photoredox-Catalyzed [3 + 2] Cycloadditions of N-Sulfonyl Cyclopropylamines with Electron-Deficient Olefins

White, Dawn H.,Noble, Adam,Booker-Milburn, Kevin I.,Aggarwal, Varinder K.

supporting information, p. 3038 - 3042 (2021/05/04)

A highly diastereoselective, visible-light-induced [3 + 2] cycloaddition between N-sulfonyl cyclopropylamines and electron-deficient olefins is reported. The reactions proceed via the oxidation of a sulfonamide aza-anion by an organic photocatalyst to generate a nitrogen-centered radical. Strain-induced ring opening and intermolecular addition to the olefin generate an intermediate carbon-centered radical that is reduced to an anion prior to 5-exo cyclization. This enables a highly diastereoselective construction of trans-cyclopentanes possessing synthetically useful functional groups.

Gram-Scale Synthesis of Chiral Cyclopropane-Containing Drugs and Drug Precursors with Engineered Myoglobin Catalysts Featuring Complementary Stereoselectivity

Bajaj, Priyanka,Sreenilayam, Gopeekrishnan,Tyagi, Vikas,Fasan, Rudi

, p. 16110 - 16114 (2016/12/26)

Engineered hemoproteins have recently emerged as promising systems for promoting asymmetric cyclopropanations, but variants featuring predictable, complementary stereoselectivity in these reactions have remained elusive. In this study, a rationally driven strategy was implemented and applied to engineer myoglobin variants capable of providing access to 1-carboxy-2-aryl-cyclopropanes with high trans-(1R,2R) selectivity and catalytic activity. The stereoselectivity of these cyclopropanation biocatalysts complements that of trans-(1S,2S)-selective variants developed here and previously. In combination with whole-cell biotransformations, these stereocomplementary biocatalysts enabled the multigram synthesis of the chiral cyclopropane core of four drugs (Tranylcypromine, Tasimelteon, Ticagrelor, and a TRPV1 inhibitor) in high yield and with excellent diastereo- and enantioselectivity (98–99.9% de; 96–99.9% ee). These biocatalytic strategies outperform currently available methods to produce these drugs.

Stereodivergent synthesis of arylcyclopropylamines by sequential C-H borylation and Suzuki-Miyaura coupling

Miyamura, Shin,Araki, Misaho,Suzuki, Takayoshi,Yamaguchi, Junichiro,Itami, Kenichiro

supporting information, p. 846 - 851 (2015/02/19)

A step-economical and stereodivergent synthesis of privileged 2-arylcyclopropylamines (ACPAs) through a C-(sp3)-H borylation and Suzuki-Miyaura coupling sequence has been developed. The iridium-catalyzed C-H borylation of N-cyclopropylpivalamide proceeds with cis selectivity. The subsequent B-cyclopropyl Suzuki-Miyaura coupling catalyzed by [PdCl2(dppf)]/Ag2O proceeds with retention of configuration at the carbon center bearing the Bpin group, while epimerization at the nitrogen-bound carbon atoms of both the starting materials and products is observed under the reaction conditions. This epimerization is, however, suppressed in the presence of O2. The present new ACPA synthesis results in not only a significant reduction in the steps required for making ACPA derivatives, but also the ability to access either isomer (cis or trans) by simply changing the atmosphere (N2 or O2) in the coupling stage.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 4548-34-9